Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-13

Clinical Trial Update: The Effect of Shigyakusan Used for IBS and MUPS Diagnosed by Abdominal N Line Tenderness [NA]

View source ↗

Summary

A completed clinical trial evaluated the use of Shigyakusan for irritable bowel syndrome and related abdominal tenderness findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shigyakusan

Snippet

Sponsor: Nakatani Clinic | Conditions: Irritable Bowel Syndrome | NA | Status: COMPLETED